tiprankstipranks
Silo Pharma (SILO)
NASDAQ:SILO
US Market
SILO
Silo Pharma
RESEARCH TOOLSreports

Silo Pharma (SILO) Income Statement

220 Followers

Silo Pharma Income Statement

Last quarter (Q1 2026), Silo Pharma's total revenue was $18.03K, a decrease of 0.00% from the same quarter last year. In Q1, Silo Pharma's net income was $-1.65M. See Silo Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 72.10K$ 72.10K$ 72.10K$ 72.10K$ 71.26K
Gross Profit
$ -813.96K$ 66.26K$ 66.26K$ 66.26K$ 66.26K
Operating Expenses
$ 3.47M$ 4.77M$ 3.92M$ 3.69M$ 2.81M
Depreciation and Amortization
$ 11.44K$ 6.18K$ 0.00$ 0.00$ 0.00
EBITDA
$ -4.28M$ -4.38M$ -3.63M$ -3.91M$ 4.19M
Operating Income
$ -4.28M$ -4.71M$ -3.86M$ -3.63M$ -2.74M
Other Income/Expenses
$ 52.96K$ 312.81K$ 224.51K$ -279.73K$ 6.93M
Pretax Income
$ -4.23M$ -4.39M$ -3.63M$ -3.91M$ 4.18M
Net Income
$ -4.23M$ -4.39M$ -3.70M$ -3.91M$ 3.90M
Per Share Metrics
Basic EPS
$ -0.50$ -1.19$ -1.20$ -1.71$ 1.32
Diluted EPS
$ -0.50$ -1.19$ -1.20$ -1.71$ 1.30
Weighted Average Shares Outstanding
 8.38M 3.68M 3.08M 2.28M 1.90M
Weighted Average Shares Outstanding (Diluted)
 8.38M 3.68M 3.08M 2.28M 1.92M
Currency in USD

Silo Pharma Earnings and Revenue History